100 Migraine drugs, A to Z: Atenolol

June 4, 2018

Atenolol (Tenormin) is a blood pressure medicine in the beta blocker family. Atenolol is considered to be equally effective in preventing migraines to propranolol (Inderal), which was the first drug to be approved for the prevention of migraines over 50 years ago. The effect of atenolol lasts all day and it can be taken once a day. It has the same side effect profile as propranolol. The most common side effects are caused by excessive lowering of blood pressure or slowing of the pulse rate and include fatigue, lightheadedness, exercise intolerance, cold extremities, and occasionally impotence, depression and insomnia. Some but not all beta blockers can worsen asthma.

You do not have to have high blood pressure to take atenolol or another beta blocker – they prevent migraines even if blood pressure is normal. We still do not know how these drugs prevent migraines. We do not prescribe beta blockers if the blood pressure is low (below 110/70) because the risk of side effects is high. However, if the blood pressure is in the middle of normal range or higher, this is a good choice. Beta blockers also help with anxiety and many performers take them only before giving a speech, a presentation, or a musical performance. Under these circumstances, a short-acting beta blocker, such as propranolol is a better choice than atenolol. Beta blockers are also very effective for the benign essential or familial tremor.

Written by
Alexander Mauskop, MD
Continue reading
September 17, 2026
Music and Pain
Music can relieve pain, but what kind of music? A new study from McGill University, published in Pain, found that music with greater emotional depth reduced pain, while intense, forceful music increased it. The effect seemed to depend on how much listeners enjoyed the music. The practical advice: choose music you love, rather than music labeled relaxing or therapeutic.
Read article
September 10, 2026
Brain disorders
Genetic connection of fibromyalgia with low back pain, PTSD, IBS, and other disorders.
A genome-wide study published in Nature Medicine found that fibromyalgia shares genetic risk factors with chronic pain conditions, IBS, PTSD, and sleep disturbances. This supports treating these overlapping conditions as one problem of a hyperexcitable nervous system rather than as separate diseases, using a multidisciplinary approach that combines psychological therapies with medications, injections, and neurostimulation.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe